Ligand Pharmaceuticals
LGND
LGND
215 hedge funds and large institutions have $2.23B invested in Ligand Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 59 increasing their positions, 89 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
34% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 89
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Holders
215
Holding in Top 10
6
Calls
$23.5M
Puts
$9.54M
Top Buyers
| 1 | +$37M | |
| 2 | +$29.8M | |
| 3 | +$22.8M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$21.4M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$12.4M |
Top Sellers
| 1 | -$27.8M | |
| 2 | -$20.8M | |
| 3 | -$20.6M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$20.6M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$15.8M |